Okada M, Tomosugi T, Futamura K, Hiramitsu T, et al. Mid-Term Outcomes After Treatment for Antibody-Mediated Rejection by De Novo Donor-Specific HLA Antibody in Renal Transplant Recipients: Does Early Treatment Lead to Better Outcomes? Transplant Proc 2020 Jul 18. pii: S0041-1345(20)30574.
PMID: 32694058